Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...
CEO Wenbin Jiang highlighted that "total revenue reached $52.3 million, representing a year-over-year increase of 2% compared to the same period in 2024." Jiang emphasized strong double-digit gains in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback